We’re big fans of life

That’s why the one and only priority of the Buck’s leadership is to support Buck science. We are at a critical inflection point in research on aging when fundamental biological discoveries are poised to become clinical realities. We believe the age of better aging starts now, and we are thrilled to be a part of it.

Our first, second, and third concerns: science, science, and science

Because of how we’re structured, how we conduct our research, and the elite collection of scientists we have working with us, the Buck is in a unique position to define the approach for solving many of the biggest problems facing the world today. The Buck’s leadership works every day to ensure our scientists have the support and resources they need as they tackle these immense challenges.

Dr. Eric Verdin

Eric Verdin is the president and chief executive officer of the Buck Institute for Research on Aging. A native of Belgium, Dr. Verdin received his Doctorate of Medicine (MD) from the University of Liege and completed additional clinical and research training at Harvard Medical School. He has held faculty positions at the University of Brussels, the National Institutes of Health (NIH), and the Picower Institute for Medical Research. Dr. Verdin is also a professor of medicine at University of California, San Francisco. Dr. Verdin joined the Buck in 2016 after spending the previous 20 years as a senior investigator at the Gladstone Institutes, where he served as associate director from 2004 to 2016.

Dr. Verdin’s laboratory focuses on the role of epigenetic regulators in the aging process. His laboratory was the first to clone a family of enzymes called HDACs, which regulate histone acetylation. Dr. Verdin studies how metabolism, diet, and small molecules regulate the activity of HDACs and sirtuins, and thereby the aging process itself and its associated diseases, including Alzheimer’s. He has published more than 210 scientific papers and holds more than 15 patents. He is a highly cited scientist and has been recognized for his research with a Glenn Award for Research in Biological Mechanisms of Aging and a senior scholarship from the Ellison Medical Foundation. He is an elected member of several scientific organizations, including the American Association for the Advancement of Science, the American Society for Clinical Investigation, and the Association of American Physicians. He also serves on the advisory council of the National Institute on Drug Abuse at the NIH.

Eric Verdin, MD

President and Chief Executive Officer

Malene Hansen, PhD

Chief Scientific Officer

Meagan Moore

Chief Administrative Officer

Nancy Derr

Vice President, Finance and Chief Financial Officer

Robin Snyder, PhD

Vice President, Communications

Remy Gross III

Vice President, Business Development and Technology Advancement

Gordon Lithgow, PhD

Vice President, Academic Affairs

Brian Van Weele

Vice President, Chief Philanthropic Officer

Danielle Herrerias

Vice President, Human Resources

Contact for more information

Juniper K. Pennypacker
Vice President, Chief of Staff
and Scientific Operations
Lauren House
Executive Assistant
Jill Stevens Kinney

Chair of the Board of Trustees

With more than 30 years of experience, Jill Kinney is an industry leader in the world of health and fitness. After founding Club One in 1991, Jill built it into a $90 million business with over 3,000 employees. She repurchased the company in 2014 and expanded its scope by establishing one of the first fitness/healthcare partnerships. Today, the company, now known as Active Wellness, is among the largest fitness management companies in the US. Jill is also a pioneer in digital health, having merged her weight loss and behavior improvement program, Itrim, with the digital wellcare platform Moni Health, a medically reimbursable, clinically validated weight loss and behavioral change program. Jill attended UC Berkeley and lives in Marin County.

Jim previously managed Chevron Corporation’s global pension assets and was subsequently a Portfolio Manager with JP Morgan Securities. He is President of the Azelora Foundation and serves on the Advisory Council for the Buck Institute for Research on Aging. Jim holds undergraduate and MBA degrees from Stanford University, as well as a PhD.
Bruce Barclay is a New Zealander/British investor, entrepreneur and philanthropist based in Switzerland. Over the course of his varied career, he has worked in a large multinational computing company, a leading venture capital backed high tech startup in machine vision, robotics and artificial intelligence in Silicon Valley and Oxford, in corporate finance and investment banking in London, and, most recently, at one of the world’s largest and most successful Private Equity Groups, Advent International, where he served as Senior Partner. At Advent he was involved as dealmaker in over $2 billion of deals, working with the venture capital operation in healthcare and life sciences as well as with the buyouts team, and also led global fundraising, raising over $20 billion. Bruce has an MBA from IMD, Lausanne, Switzerland.
Andy Barnes is founder and principal of Barnes and Company, which provides consulting and advisory services to organizations having complex land-use needs and sustainable development objectives. He utilizes his career experiences to help build better places to live and work and to achieve more viable cities, emphasizing smart growth techniques. Andy was previously CEO of the Stapleton Development Company in Denver. Earlier in his career, he was the Executive Director of the Pennsylvania Avenue Development Corporation, for which he received the Presidential Design Award. Andy is a graduate of Yale University and Harvard Business School, and is a former White House Fellow and German Marshall Fund Fellow. He serves on the boards of Greenbelt Alliance and SPUR (San Francisco Planning and Urban Development), and is a past chair of both organizations’ boards.
Dr. Buzzitta is a board certified internal medicine physician in Grand Rapids, Michigan, and the founder and former CEO of the largest private physician-owned multi-specialty group in Michigan. He is currently president of Hughes Management LC, a real estate development company, and Hughes Ventures LLC, a private equity/venture capital company. Dr. Buzzitta has served on multiple boards, including the Spectrum Health System, the Michigan Professional Insurance Exchange, Priority Health, and the Grand Valley State University Foundation. He has spoken locally, regionally and nationally on the topics of physician integration, physician-hospital integration, healthcare economics, healthcare system strategies, the monetization of real estate, and healthcare system research and innovation strategies.
Matt co-founded AIM in 2006 and has nearly 30 years of experience in private equity and corporate finance. He has sourced, managed, and/or executed more than 90 transactions worth over $10 billion. Prior to joining AIM, he founded and led Wit Capital Group’s West Coast operations growth to more than 100 employees and was responsible for building and managing the firm’s investment banking operations. He was a member of its Executive, Management, and Commitment Committees. Earlier, Mr. Carbone worked in the investment banking divisions of Morgan Stanley, the First Boston Corporation and Smith Barney. Matt currently serves on the Boards for Landmark Infrastructure Partners, LP (Chairman), Landmark Dividend LLC (Chairman), Tunnel Hill Partners and Arrow Material Services.
Dottie Dutton started her career in institutional and private wealth management with the California State Teachers Public Retirement System and became its CIO for fixed-income investments. She then worked at two private money management firms, Delaware Investment Advisors and Scudder, Stevens, and Clark, where she was a senior portfolio manager and partner. In 2006, she opened the Private Client Reserve office for U.S. Bank in San Francisco and spent 10 years building out their wealth management services in Northern California. Dottie currently works as a consultant with Evercore Wealth Management in San Francisco. She sits on the board of directors for Saint Francis Medical Foundation and is a member of the Medical Council Advisory Board for National University of Singapore. Her previous board roles have included the San Francisco Estate Planning Council, where she was the president of the board, and the board of directors for Girls Scouts Council of Northern California.
David currently manages a vineyard in Sonoma County, is involved in several real estate development projects, is on the board of several companies in the real estate and technology space and serves on the Advisory Council for the Stanford Distinguished Career Institute. He has been actively involved in a number of civic organizations including the Cornell College of Art, Architecture and Planning, the Cornell School of Human Ecology and Junior Achievement of Southern California.

David spent much of his career at Gensler, the largest design firm in the world with 46 offices in 16 countries. Gensler provides architecture, design, planning and consulting services to over 2,500 clients. During his 23 years there, he helped grow the company from 500 people and $60M of revenue to over 5,000 people and $1.1B of revenue. He led the firm’s consulting practice, started the firm’s information solutions practice, was a Regional Managing Principal of EMEA, was the Chief Operating Officer and served on Gensler’s Board of Directors and Executive Committee for 12 years. For the last 10 years of his career there he was Co-CEO. As co-CEO, he was responsible for the firm’s operational infrastructure, including Finance, Global Talent, Legal/Risk Management, Communications, Public Relations, Practice Area Marketing, Applications Development, Technology, Global Advisory Services, Design Practice, and Research. David also had oversight responsibility for the firm’s EMEA, Asian and South American practices.

Prior to his career at Gensler, David worked across a number of fields including Financial Services at Morgan Stanley and the Pacific Stock Exchange, Technology at Microsoft and Datis Corp. and Management Consulting at Edgar, Dunn and Company.

Mr. Gensler holds an MBA from Stanford University and a BA in Economics from Dartmouth College. David lives in Sebastopol California, is an active athlete and has four daughters.
Lydia Graham’s career intersects communications, health, and business and spans the national and international marketing, public relations, management, and entrepreneurship sectors. As president and CEO of Graham & Associates, Inc., a highly awarded communications and public relations company headquartered in San Francisco, she works as a creative strategist for clients in the American, European, and Asian markets and is recognized for her innovation and creativity in launching and re-launching new and established companies, divisions, and products in technology, health and wellness, and consumer goods and services. She has successfully concepted and launched new emerging categories, receiving more than 100 awards nationally and internationally. Her work in the health sector has focused specifically on life sciences, healthy living and aging, and longevity. Additionally, she is a partner and investor in several recognized national brands. Early in her career, she held marketing management positions for Qantas Airways HQ North America. She began her business career in management consulting after founding a natural foods company. She is a passionate evangelist for healthy living and healthy aging.
Mike Ghilotti has been president of Ghilotti Bros., the North Bay's fifth-largest commercial contractor, since 2000. Part of the third generation to run the 90-year-old general engineering contractor, Mr. Ghilotti started with the family business while a college student, lubricating machinery full-time during the summers. Upon graduating from St. Mary's College in 1984 with a degree in construction management, he began managing company operations as a project manager. After two years, he took the helm of the company's North Bay region. Meanwhile, studying at night and on weekends, he earned his MBA from Golden Gate University in 1987.

Mr. Ghilotti was president of the Association of Engineering Contract Employers in 2000 and is co-chair of the California Save the Missions Foundation.
John M. Jack has worked in the software industry since 1980 in sales, marketing, and executive management. Highlights of his career include serving as chief executive officer at Fortify Software (sold to Hewlett-Packard) and at Covalent (sold to VMware), serving as chief operating officer at The Vantive Corporation (public, sold to PeopleSoft), and holding executive positions at Sybase, Inc. Since leaving Hewlett-Packard in January of 2012, he has served as a consultant to start-up companies and their CEOs. JJ currently serves on a number of venture-backed company boards in cyber-security and other segments of the technology industry. He is also a board partner at the venture capital firm Andreessen Horowitz.
Edward Lanphier is a former president and CEO of the Buck Institute for Research on Aging and has served as a Buck trustee since 2012. With more than 30 years of experience in the biotechnology industry, Edward is a globally recognized leader in the biopharmaceutical industry. Throughout his professional career, he has been on the forefront of health innovations and therapeutic solutions. In 1995, Edward founded Sangamo BioSciences, a clinical stage biopharmaceutical company that researches and conducts gene therapy and genome editing. Edward served as the company’s president and CEO from its inception until June 2016, and he currently serves as chairman of Sangamo’s board of directors. He previously served as chairman of the board of directors for the Alliance for Regenerative Medicine and is a member of the board of directors for the Biotechnology Institute and the University of Michigan School of Public Health’s Dean’s Advisory Board. He has significant nonprofit experience with globally focused research and advocacy organizations. Before founding Sangamo, he held management positions at some of the pharmaceutical and biotechnology industry’s most respected companies, including Eli Lilly, Synergen, and Somatix.
Lizellen La Follette, MD, is a board-certified OB-GYN in private practice in Greenbrae, California. She offers women personalized, comprehensive healthcare, including both low & high risk obstetric services, wellness woman exams , Dr. La Follette established her own healthcare practice in 2004. A noted leader and educator in women’s health issues and vaginal birth after cesarean (VBAC) deliveries, Dr. La Follette also serves as medical advisor to innovative technology start-ups focused on improving women’s health and patient education. She is a member of the newly formed Global Consortium for Reproductive Longevity & Equality (CRLE) at the Buck Institute for Research on Aging. (https://www.drlafollette.com/)
Linda Furst Mayne owned and operated her own real estate company, Mayne & Company, in San Francisco and Marin for 33 years before joining Sotheby’s International Real Estate as a broker associate. Linda has served on the board of directors of One Purpose School, a nonprofit charter school in San Francisco whose purpose was to disrupt the cycle of poverty in San Francisco’s highest-poverty neighborhoods; on the advisory council for Institute for Health and Healing of California Pacific Medical Center; and as Marin board chair for Women’s Initiative for Self-Employment. A lifelong artist, Linda is on the Modern Art Council for the San Francisco Museum of Modern Art.
Dr. Afaf Meleis’s research scholarship focuses on global health, women's health, culturally competent practice, interprofessional education, and epistemological development and progress in the discipline of nursing. Much of her life's work has been dedicated to uncovering the voices of vulnerable populations and to developing “transitions theory,” which is used globally and has been translated into policy, research, and evidence-based-practice. Dr. Meleis is the author of over 200 articles and books in nursing, medical, and social science journals. She speaks and consults widely in Latin America, Southeast Asia, Europe, and the Middle East, addressing social inequities facing women and marginalized populations. Dr. Meleis is the recipient of numerous awards as well as honorary doctorates from national and international universities. She is a graduate of the University of Alexandria, Egypt, and the University of California, Los Angeles. She is a professor of nursing and sociology and dean emeritus at the University of Pennsylvania School of Nursing. She is also a professor emeritus at University of California, San Francisco, and a member of the National Academy of Medicine, the American Academy of Nursing, and other societies.
Jim Mellon is a British entrepreneur and philanthropist. He is co-founder and chairman of Juvenescence, a British Virgin Islands–based holding company that invests in human aging and longevity. He is chairman of Regent Pacific Group Limited, a Hong Kong–listed investment company that specializes in growth- and value-led investments in health care and late-stage life science assets. Jim is coauthor of Juvenescence: Investing in the Age of Longevity.

Alan Mendelson retired as a partner of Latham & Watkins LLP in December 2020. He was a member of the Silicon Valley office of the firm and served as Co-Chair of the firm’s Emerging Companies Group and Life Sciences Industry Group for many years. He joined the firm in May 2000, bringing a wealth of practice and management experience in the areas of corporate and securities law. Mr. Mendelson is a member of the Board of Trustees of the UC Berkeley Foundation and previously served as President of the California Alumni Association and as an alumni regent of the University of California. He has served as the corporate secretary for many public and private companies and currently serves on the board of directors of Coherus BioSciences, Inc., BBI Medical Solutions, LLC, Neuvogen, Inc. and Xomics Biopharma, Inc. Mr. Mendelson was recognized as one of America’s 100 most influential lawyers in the 1994, 1997, 2000 and 2006 editions of the National Law Journal and as one of “California’s 100 Most Influential Lawyers” in 1998 and 1999 editions of California Law Business.
Bill Poland is Chairman Emeritus at the Buck Institute. A real estate entrepreneur, Bill is founder and president of Bay West Group, a commercial real estate development company committed to creating value in the development of urban infill, opportunistic, and adaptive reuse projects. He is a member of the Georgia Tech President’s Advisory Board, the Urban Land Institute, and the board of the Steers Global Real Estate Center at Georgetown University. Previously, Bill served as chair of the San Francisco Convention and Visitors Bureau, president of the Olympic Club in San Francisco, and councilmember of the town of Ross, California. Bill holds a BA in mechanical engineering from Georgia Tech and an MBA from Stanford.
Steven Read is a Founding Partner of Read Investments, a preeminent boutique commercial real estate firm operating throughout the Bay Area, Northern California, and the Pacific Northwest. He is the former CEO and Chairman of the Board of Grocery Outlet, Inc, a 300-store chain operating in eight western states. An avid skier and cyclist, Read is a current member of the Board of Trustees of the Steadman-Philippon Institute Sports Medicine Foundation, the USSA Ski Team, and the United States Olympic Committee. He is also a member of the UCSF Board of Overseers. Previous board roles include the Fine Arts Museums of San Francisco, Oakland Museum of California, San Francisco Opera, Duke University, and the University of San Francisco.
Wendye is a physician scientist and biopharmaceutical entrepreneur with extensive operational, strategy, fund raising, and team building experience. She joined Blade in 2015. Wendye has made a career of building companies from the ground up. She has collaborated with diverse investor groups to co-found and managed several nascent biopharmaceutical companies (including Blade, Labrys, NeurogesX among others). Additionally, she functions as a strategic and scientific advisor to innovators and investors, and serves as an independent board member and head of the pricing and transaction subcommittees for Rapt Therapeutics (NASDAQ: RAPT) and board member for the California Life Sciences Association. Her expertise includes small and large molecule development from discovery through translational research through the clinic.
Wendye received her BS from the Haas School of Business, University of California, Berkeley and her MD from the Medical College of Pennsylvania. She completed postgraduate training in internal medicine at the Hospital of the University of Pennsylvania and in anesthesiology and pain at the Johns Hopkins University Medical Institutions. She served as Assistant Professor of Anesthesiology at UCSF from 1995-2000 and has been teaching faculty at the Stanford University School of Medicine since 2002. She is board certified in anesthesiology.
From 2000 until his retirement in late 2006, Dr. Rowe served as Chairman and CEO of Aetna, Inc., one of the nation’s leading health care and related benefits organizations. Before his tenure at Aetna, from 1998 to 2000, Dr. Rowe served as President and Chief Executive Officer of Mount Sinai NYU Health, one of the nation’s largest academic health care organizations. From 1988 to 1998, prior to the Mount Sinai-NYU Health merger, he was President of the Mount Sinai Hospital and the Mount Sinai School of Medicine in New York City. Before joining Mount Sinai, he was a Professor of Medicine and the founding Director of the Division on Aging at the Harvard Medical School, as well as Chief of Gerontology at Boston’s Beth Israel Hospital. Currently, Dr. Rowe chairs the MacArthur Foundation’s Research Network on an Aging Society and chairs the Institute of Medicine’s Forum on Aging, Disability and Independence. He was elected a member of the Institute of Medicine of the National Academy of Sciences and a Fellow of the American Academy of Arts and Sciences. In addition, he serves on the Board of Trustees of the Rockefeller Foundation and is a former member of the Medicare Payment Advisory Commission (MedPAC). Dr. Rowe is also Chairman of the Board of Trustees at Marine Biological Laboratory in Woods Hole, Massachusetts and Founding Chairman of Stanford's Center on Longevity’s External Advisory Council.
Theo has 37 years of experience in the investment and wealth advisory business, and is a Certified Wealth Strategist®. She started her career trading foreign currencies, gold and silver, and also acted as the municipal bond coordinator for Dean Witter, one of the largest San Francisco offices during the 1980’s. In the 1990's, she ran an equity portfolio and coordinated the Branch Investment Consulting Services.

Her current position, Senior Vice President of "The Schwabacher Group" at Morgan Stanley. She concentrates on consulting for affluent families. Her comprehensive planning includes helping with asset allocation, assisting with investment policy formulation, manager search, performance monitoring and due diligence. Each client’s investment plan is customized, providing access to tax advice, estate planning strategies, philanthropic objectives with family and institutional goals. Theo is a fourth generation San Franciscan. Her grandfather and father were both involved in the brokerage and investment banking business and sold their company, Schwabacher and Co. to Dean Witter in 1968.

Her own philanthropic participation has led her to participate on many boards in San Francisco. These include the San Francisco Cancer Society, Red Cross, San Francisco Mental Health Association, Merola and the San Francisco Opera Board. Her professional associations include Technical Analysts Association of San Francisco, Certified Investment Management, and the Morgan Stanley Presidents Club from 2006-present. Her current affiliations include: Morgan Stanley Women’s Business Exchange, The Women’s Global Warming Initiative, and National Women Board of Entrepreneurs. She co-chairs Women Corporate Directors Foundation of Northern California, which helps create diversity on public boards.

Fredric Steck is a retired partner of Goldman Sachs, a leading global investment banking and securities firm. During his 25 years with the investment bank, Mr. Steck held a number of leadership positions, including National Sales Manager for the Fixed Income Currency and Commodities Division.

Mr. Steck is a member of the board of Aravo Solutions, Inc. an enterprise software company addressing the issue of third party risk and compliance. He is Chairman of DNP, a holding company with a major investment in Thorne Research, a science based health and wellness company. Mr. Steck has served in many capacities on the UC Santa Barbara Foundation Board including Chairman and vice-Chairman of Development.

Mr. Steck is a private investor with interests in entrepreneurship, education, and environment. He is the sole donor and a trustee of the Fredric E. Steck Family Foundation in Santa Ynez.
Richard Stone, CLU, CFP, is the founder and chairman of Private Ocean, which is widely recognized as one of the most successful progressive wealth management advisory firms in the country. He has been engaged in investing and financial planning in the Bay Area for more than 40 years. He was awarded the prestigious 2011 Schwab IMPACT Leadership Award, which recognizes advisors and firms that have advanced the industry through their visionary leadership, innovative practices, and exceptional growth. The Leadership Award, one of three IMPACT Awards, recognizes his embodiment of the value of independent investment advice through vision, commitment, and community engagement. He is chairman of the Personal Financial Planning Advisory Board at UC Berkeley Extension. He also serves as a member of both the Dominican University board of trustees and the Global Business Council at San Jose State.
Eric Verdin, MD, became president and chief executive officer of the Buck Institute in November 2016. Eric joined the Buck from the Gladstone Institute for Virology and Immunology, where he served as associate director and senior investigator. He has held faculty positions at the University of Brussels, the National Institutes of Health (NIH), and the Picower Institute for Medical Research. Eric is also a professor of medicine at University of California, San Francisco. The Verdin lab focuses on how metabolism, diet, and small molecules regulate a family of key proteins and, as a result, the aging process and its associated diseases. Eric has published more than 210 scientific papers and holds more than 15 patents. A native of Belgium, he earned his MD from the University of Liege and completed additional training at Harvard Medical School.
Wells Whitney was born in 1933 and brought up in New York City and Boston. He got his BA from Harvard College and MS and ScD from MIT and then did a postdoc year in Strasbourg, France. Over the next few years, he worked on the East Coast for Monsanto, Celanese, and Reprographic Materials in various research and product development positions. In the early 1970s, he moved to the Bay Area and worked for Raychem in Menlo Park for the next 25 years doing research, product development, and exploratory marketing, including three years in Tokyo. After retiring from Raychem, he did several small start-ups, consulted for various technology companies, and served on many local nonprofit boards focusing on urban affairs, immigration, health, and neighborhood improvement. Since he joined the Buck’s board of trustees, he has become very interested in the science of aging. He works in the community leading men’s groups on aging, giving lectures, and teaching sessions on how to have a longer healthy lifespan.
Dr. Joon Yun is President and Managing Partner of Palo Alto Investors LP, a healthcare hedge fund founded in 1989. Board certified in radiology, Joon served on the clinical faculty at Stanford from 2000-2006. Joon has served on numerous boards, and he is currently a trustee of the Salk Institute. Joon is a member of the President's Circle of the National Academies of Sciences, Engineering, and Medicine. Joon has published dozens of patents and scientific articles. Joon and his wife Kimberly launched the $1 million Palo Alto Longevity Prize in 2013 to reverse the aging process and recently donated $2 million to launch the National Academy of Medicine Aging and Longevity Grand Challenge. Fun fact: Joon has been going to Burning Man consecutively for the past 18 years.
Professor Emeritus, Biochemistry and Biophysics
UCSF School of Medicine
Professor, Microbiology & Immunology
Stanford University
Professor of Developmental and Molecular Biology
Co-Director, Einstein Institute for Aging Research
Albert Einstein College of Medicine

Professor of Molecular and Cell Biology
Thomas and Stacey Siebel Distinguished Chair in Stem Cell Research
Howard Hughes Medical Investigator
University of California, Berkeley
Professor, Laboratory of Genetics
Vi and John Adler Chair for Research on Age-Related Neurodegenerative Disease
The Salk Institute

Director, Professor, Cellular Biochemistry
Max Planck Institute of Biochemistry
Senior Investigator, Head of the Section on Integrative Physiology and Metabolism at Joslin Diabetes Center
Mary K. Iacocca Professor of Medicine
Harvard Medical School

A.W. and Mary Clausen Distinguished Professor of Neurology
Director, Memory and Aging Center
University of California, San Francisco

Professor of Molecular Biology and the Lewis-Sigler Institute for Integrative Genomics
Princeton University
Professor, Neurology & Neurological Sciences, Stanford University
Associate Professor of Neurology
Harvard Medical School
Professor of Biochemistry and Biophysics
Howard Hughes Investigator
University of California, San Francisco
Dick Bodman is chairman of TDF Ventures, a venture capital firm and foundation based in Washington, D.C. He is also the managing general partner of VMS Group, president of Venture Management Services, Inc., and a managing member of VMS Fund Administration, LLC (VMSFA), all of which perform administrative and advisory services for venture capital funds. He is co-founder and chairman of PurThread Technologies, Inc., which makes antimicrobial textile products. He is also the managing manager of Bodman Oil & Gas, LLC, and a board member of the La Jolla Institute for Immunology and Allergy. From 1990 to 1996, he was senior vice president for strategy and development at AT&T, lead director at Sandia National Laboratories, and founder and chairman of AT&T Ventures. From 1973 to 1990, he held various management and C-level positions in a private equity firm, communication and satellite corporations, and a major American conglomerate. He also served as assistant secretary of the U.S. Department of the Interior and, subsequently, as assistant director of the Office of Management and Budget in the Office of the President between 1971 and 1973.
Darla Flanagan has been a commercial real estate investment and finance executive for over 35 years. She currently owns and manages a portfolio of commercial assets for her family investment company, MKD Investments. She also founded Fowler Flanagan Partners, a real estate investment firm, and was an executive of JMB Realty for 12 years. She has served on the boards of numerous organizations, including Catellus Development Company, The Branson School, Blue Oak School, and Adopt-a-Family of Marin.
Art Gensler founded the Gensler firm (M. Arthur Gensler, Jr. & Associates) in 1965. An architect, he is widely credited with elevating the practice of interior design to professional standing. He is a fellow of both the American Institute of Architects and the International Interior Design Association (IIDA), and he is a professional member of the Royal Institute of British Architects. Art graduated from Cornell University’s College of Architecture, Art and Planning and is a member of its advisory council. A charter member of Interior Design magazine’s Hall of Fame and a recipient of IIDA’s Star Award, he has also received Ernst & Young LLP’s Lifetime Achievement Award and the Cornell Entrepreneur of the Year Award. In 2015, he wrote Art’s Principles to offer today’s entrepreneurs the business insights he wishes someone had given him when he was starting out. Art’s notable architecture projects include John F. Kennedy International Airport (NYC), Ritz-Carlton Hotel (Dubai International Financial Centre), Houston Ballet Center for Dance, San Francisco International Airport, The Avenues (Kuwait City), Facebook (London), Duke Kunshan University (China), Shanghai Tower, and Tower at PNC Plaza (Pittsburgh, PA).
Charles S. La Follette is the President of La Follette Capital, a consulting firm. Prior to starting La Follette Capital, Mr. La Follette served as Senior Vice President and Chief Financial Officer of California Energy Company, Inc. He also held positions as Chief Financial Officer of Chronicle Publishing, Executive Vice President of U.S. Leasing, Senior Vice President and Chief Financial Officer of CBS, Inc. as well as Executive Vice President of Crown Zellerbach. His past business directorships include the Pacific Stock Exchange, U.S. Leasing International, and Crown Zellerbach. Mr. La Follette’s non-profit directorship positions consist of Finance Chairman of California-Pacific Medical Center Foundation, Trustee Emeritus of the Archaeological Institute of America, Board Member of San Francisco Art Institute and the San Francisco Ballet, as well as, Chair of the Investment Committee of Marin Community Foundation to name a few.

Mr. La Follette received a B.S. and an M.B.A. from Harvard University. Mr. La Follette resides in San Francisco with his wife, Ellen. They have four grown children that all attended Harvard as well.
John Larson is a retired San Francisco attorney with over 40 years of practice devoted to high-tech and life science companies. John left as a partner at the law firm of Morgan, Lewis & Bockius LLP in December 2009 after joining the firm in 2003. Previously, he had served as partner at the law firm of Brobeck, Phleger & Harrison LLP from 1969 until retiring in January 2003, except between July 1971 to September 1973, when he served as Assistant Secretary of the United States Department of the Interior and Counselor to George P. Shultz, chairman of the Cost of Living Council. From 1988 until March 1996, John served as the CEO for Brobeck. He also served on the board of directors of Sangamo Biosciences, Inc. for 20 years. He is a former chair of the San Francisco Chamber of Commerce and past president of The Branson School’s board of trustees. John served as chairman of the board of directors for WageWorks, a NYSE company, from 2006 until 2016, and he currently serves as an independent director for the board.
Bill Poland is Chairman Emeritus at the Buck Institute. A real estate entrepreneur, Bill is founder and president of Bay West Group, a commercial real estate development company committed to creating value in the development of urban infill, opportunistic, and adaptive reuse projects. He is a member of the Georgia Tech President’s Advisory Board, the Urban Land Institute, and the board of the Steers Global Real Estate Center at Georgetown University. Previously, Bill served as chair of the San Francisco Convention and Visitors Bureau, president of the Olympic Club in San Francisco, and councilmember of the town of Ross, California. Bill holds a BA in mechanical engineering from Georgia Tech and an MBA from Stanford.
Lewis Reid was a founder of Marron-Reid, LLC, a Northern California law firm that has its home office in San Francisco. He practiced law for over three decades, primarily in the areas of corporate transactions and tax law. In 1998, he left law practice to become president and CEO of The California Endowment, the largest health-related charitable foundation in California. He stepped down as the foundation’s president and CEO in 2000 and remained on its board of trustees until 2009. Lewis is currently a director of the Larry L. Hillblom Foundation, a private foundation devoted to research in diabetes and diseases of aging. His previous professional positions include lecturer in law at University of California, Berkeley, School of Law and minority counsel for the U.S. Senate Committee on Interior and Insular Affairs. He is a former chairman of the board at the Buck.
Larry Rosenberger assumed the role of Fair Isaac’s first research fellow in October 2007 and currently fulfills that role on a half-time basis, continuing a career with the company that began in 1974. From 1999 to 2007, he led Fair Isaac’s Research Unit, which was focused on early-stage innovation in predictive and decision analytics aimed at helping consumer products and services clients make better decisions on their prospects and customers. From 1991 to 1999, he served as Fair Isaac’s president and CEO. During that time, Fair Isaac experienced consecutive years of record growth, with annual revenues increasing from $31 million to over $276 million. Prior to that position, he led the Engineering, Research, and Development Division, which was focused on the technical development, production, and marketing of the company's most advanced products, such as TRIAD adaptive control and the FICO score, as well as advances in predictive analytics methodology. In addition to board work, he informally advises a number of for-profit and nonprofit organizations. He co-authored The Deciding Factor: The Power of Analytics to Make Every Decision a Winner (2009).
Richard Rosenberg is a retired chairman and CEO of Bank of America. He is also a retired commander in the U.S. Naval Reserve, a member of the California Bar Association, a trustee of the California Institute of Technology, a past president of the Bank Marketing Association and the Federal Advisory Council of the Federal Reserve System, and a past chairman of MasterCard International and the United Way of the Bay Area. Richard has served as director of the Buck Institute for Research on Aging, Saga Foods, the San Francisco Symphony, and the Naval War College Foundation. He has also served as chairman of the executive councils of UCSF Medical Center, Airborne Express Corporation, SBC Communications, UCSF-Stanford Health Care, Chronicle Publishing Company, Northrup Grumman Corporation, Health Care Property Inc., and Pacific Life Insurance Company. He is a member of the American Academy of Arts and Sciences. He has been named to the Bay Area Business Hall of Fame and has received the Horatio Alger Award.
Charles M. Stockholm is a semi-retired business executive with over 50 years of commercial financial experience primarily in the Asia Pacific region. He currently serves as an advisor to the TCW Group. He also served as Chairman of Citibank International, and was Senior Executive Vice President of Crocker National Bank, and Managing Director of Trust Company of the West. He served as Chairman of Alexander & Baldwin, Inc., and Matson Navigation Company. He has served on a number of corporate boards in Japan, Indonesia, India, Malaysia, and Taiwan. Mr. Stockholm served on the San Francisco Chamber of Commerce Board, was President of the Bay Area Council of the Boy Scouts of America, President of the Asian Art Museum Foundation of San Francisco, and is a Trustee Emeritus of the Honolulu Academy of Arts. Mr. Stockholm graduated from Stanford University with a BA in Economics, and completed graduate work at the American Graduate School of International Management and the Harvard PMD Program. He is a resident of Marin County.

A mission-driven community of investigators

The Buck is a collective of the world’s top scientists in the field of aging who are sharing their methods and expertise to find ways to help everyone lead fuller, healthier lives by ending age-related disease.

Our team

Support the Buck

We rely on donations to support the science that we believe will add years to people's lifespan and decades to their healthspan.